140 related articles for article (PubMed ID: 25897433)
1. Bone morphogenetic protein 4 (BMP-4) and epidermal growth factor (EGF) inhibit metalloproteinase-9 (MMP-9) expression in cancer cells.
Laulan NB; St-Pierre Y
Oncoscience; 2015; 2(3):309-16. PubMed ID: 25897433
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic protein-2 enhances the motility of chondrosarcoma cells via activation of matrix metalloproteinase-13.
Hou CH; Hsiao YC; Fong YC; Tang CH
Bone; 2009 Feb; 44(2):233-42. PubMed ID: 19038372
[TBL] [Abstract][Full Text] [Related]
3. Regulation of matrix metalloproteinase-13 and tissue inhibitor of matrix metalloproteinase-1 gene expression by WNT3A and bone morphogenetic protein-2 in osteoblastic differentiation.
Nakashima A; Tamura M
Front Biosci; 2006 May; 11():1667-78. PubMed ID: 16368545
[TBL] [Abstract][Full Text] [Related]
4. Role of Smad1 and Smad4 proteins in the induction of p21WAF1,Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells.
Pouliot F; Labrie C
J Endocrinol; 2002 Jan; 172(1):187-98. PubMed ID: 11786386
[TBL] [Abstract][Full Text] [Related]
5. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
[TBL] [Abstract][Full Text] [Related]
6. BMP-6 inhibits the metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Hu F; Zhang Y; Li M; Zhao L; Chen J; Yang S; Zhang X
Oncol Rep; 2016 Mar; 35(3):1823-30. PubMed ID: 26751737
[TBL] [Abstract][Full Text] [Related]
7. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor.
Clement JH; Sänger J; Höffken K
Int J Cancer; 1999 Jan; 80(2):250-6. PubMed ID: 9935207
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
Li CC; Yao HT; Cheng FJ; Hsieh YH; Lu CY; Wu CC; Liu KL; Chang JW
Nutr Cancer; 2015; 67(5):771-82. PubMed ID: 25970488
[TBL] [Abstract][Full Text] [Related]
9. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.
Lee H; O'Meara SJ; O'Brien C; Kane R
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4291-9. PubMed ID: 17724219
[TBL] [Abstract][Full Text] [Related]
10. Role of matrix metalloproteinase-10 in the BMP-2 inducing osteoblastic differentiation.
Mao L; Yano M; Kawao N; Tamura Y; Okada K; Kaji H
Endocr J; 2013; 60(12):1309-19. PubMed ID: 24077220
[TBL] [Abstract][Full Text] [Related]
11. Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NFκB/c-Jun activation in breast cancer MDA-MB-231 cells.
Chen YJ; Lee YC; Huang CH; Chang LS
Toxicol Appl Pharmacol; 2016 Nov; 310():98-107. PubMed ID: 27634460
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.
Mimori K; Yamashita K; Ohta M; Yoshinaga K; Ishikawa K; Ishii H; Utsunomiya T; Barnard GF; Inoue H; Mori M
Clin Cancer Res; 2004 Dec; 10(24):8243-9. PubMed ID: 15623600
[TBL] [Abstract][Full Text] [Related]
13. Fisetin inhibits epidermal growth factor-induced migration of ARPE-19 cells by suppression of AKT activation and Sp1-dependent MMP-9 expression.
Lin HY; Chen YS; Wang K; Chien HW; Hsieh YH; Yang SF
Mol Vis; 2017; 23():900-910. PubMed ID: 29296070
[TBL] [Abstract][Full Text] [Related]
14. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor-mediated regulation of matrix metalloproteinase-2 and matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Majumder A; Ray S; Banerji A
Mol Cell Biochem; 2019 Feb; 452(1-2):111-121. PubMed ID: 30074136
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
Kondapaka SB; Fridman R; Reddy KB
Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?
Glister C; Richards SL; Knight PG
Endocrinology; 2005 Apr; 146(4):1883-92. PubMed ID: 15625241
[TBL] [Abstract][Full Text] [Related]
18. EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.
Kim S; Choi JH; Lim HI; Lee SK; Kim WW; Cho S; Kim JS; Kim JH; Choe JH; Nam SJ; Lee JE; Yang JH
Cell Signal; 2009 Jun; 21(6):892-8. PubMed ID: 19385051
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
20. [Effect of epidermal growth factor on the expression of matrix metalloproteinase-9 and the signalling pathways involved in the trophoblast cell line JEG-3].
Ren HB; Jiang ZY; Sun LZ; Fan MS; Zou YF
Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):521-6. PubMed ID: 22041445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
